Market Entry Intelligence
Launch readiness blocked by the gap between clinical conviction and investor grade commercial intelligence.
- Timeline
- Six week primary engagement with a structured handoff of the financial model and ongoing availability for investor Q&A support.
- Scope
- Market intelligence, competitive landscape analysis, unit economics modelling, and investor narrative development for a pre launch medical aesthetics operator.
- Model
- Small advisory team embedded with the founding group. Weekly synthesis sessions to pressure test assumptions. Final outputs designed for both investor consumption and internal operating use.
The outcome
Structured market entry framework that reduced due diligence cycles and supported a first close raise within the target window.
Findings
What we built it around.
Demand signal aggregation
demographic data, search intent, social listening, and treatment category growth rates synthesised into a local addressable market estimate
Competitive mapping layer
tiered analysis of existing operators by location, service breadth, pricing signals, digital presence, and estimated capacity utilisation
Unit economics model
bottom up revenue build from patient acquisition cost assumptions, visit frequency benchmarks, treatment mix, and EBITDA sensitivity to retention rate
Whitespace identification
gap analysis across treatment categories, price points, and patient demographics to identify underserved positioning
Investor narrative structuring
translation of quantitative findings into a defensible thesis with clearly stated assumptions and risk factors
Results
What changed.
Investor ready market entry pack delivered in 6 weeks, reducing the founding team's pre raise preparation time by an estimated 60% versus a self directed research approach
Unit economics model identified that retention rate at month 12 was the single most sensitive variable in achieving target EBITDA, this became the operational focus for the first year of trading
Competitive whitespace analysis surfaced a mid market positioning gap that existing operators had not addressed, informing a pricing and service architecture that was meaningfully distinct from both the premium clinic tier and the corporate medspa model
First investor close achieved within the target window; lead investor cited the analytical rigour of market sizing and unit economics as a key confidence signal
Takeaway
Structured market entry framework that reduced due diligence cycles and supported a first close raise within the target window.
Medical Aesthetics
Start a discovery
Most engagements begin with a conversation about context.
We do not send a proposal before we understand the problem. Start by telling us about your decision context. We will identify the highest leverage intervention areas before any scope is agreed.